Allurion Technologies (ALUR) Long-Term Deferred Tax (2022 - 2023)
Allurion Technologies (ALUR) posted Long-Term Deferred Tax of $1.6 million for Q4 2023, up 106.57% on a QoQ basis from $792000.0 in Q4 2022, and up 106.57% year-over-year from $792000.0 in Q4 2022.
Allurion Technologies (ALUR) Long-Term Deferred Tax (2022 - 2023) Analysis & Trends
Allurion Technologies' Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $1.6 million for Q4 2023.
- Quarterly Long-Term Deferred Tax rose 106.57% year-over-year to $1.6 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.6 million (up 106.57% YoY) and the FY2023 annual result came in at $1.6 million, up 106.57% from the prior year.
- Long-Term Deferred Tax was $1.6 million for Q4 2023 at Allurion Technologies, up from $792000.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $1.6 million in Q4 2023 and bottomed at $792000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.64 Mn |
| Dec 31, 2022 | 792,000.00 |